Triple negative breast cancer (TNBC), accounting for approximately 15% of all BC cases, is characterised by the absence of the oestrogen receptor (ER), progesterone receptor (PR) and lack of amplification of the human epidermal growth factor receptor 2 (HER2) [2]. Here, ERBB2 is linked to triple-negative breast carcinoma.